Back to Search Start Over

Abivax, Lexeo go public while sleep apnea biotech Apnimed bides its time.

Authors :
Bayer, Max
Source :
FierceBiotech; 10/2/2023, pN.PAG-N.PAG, 1p
Publication Year :
2023

Abstract

Lexeo Therapeutics and Abivax are headed to Wall Street, filing IPOs late Friday while others wait and see. [ABSTRACT FROM AUTHOR]

Subjects

Subjects :
WALL Street (New York, N.Y.)
SLEEP apnea syndromes
GOING public (Securities)

Details

Language :
English
Database :
Complementary Index
Journal :
FierceBiotech
Publication Type :
Periodical
Accession number :
172784666

Tools

Authors Abstract Subjects Details